simethicone and Metabolic-Syndrome

simethicone has been researched along with Metabolic-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for simethicone and Metabolic-Syndrome

Article	Year
Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort. Clinical research in cardiology : official journal of the German Cardiac Society, 2018, Volume: 107, Issue:10 Diastolic dysfunction (DD) is increasingly common. However, its metabolic determinants are poorly known. This study aims to determine which metabolic and inflammatory features predict DD in initially healthy adults.. We prospectively analyzed the association between metabolic features and DD in 728 initially healthy adults aged 30-60 from Eastern France enrolled in the STANISLAS population-based cohort. Clinical and biological cardiovascular features were collected at baseline (1994-1995). DD was assessed twenty years later (2011-2016) by echocardiography using current international guidelines. For replication purposes, 1463 subjects from the Malmö Preventive Project cohort were analyzed.. In the STANISLAS cohort, 191 subjects (26.2%) developed DD. In age-sex-adjusted logistic models, significant predictors of DD were body mass index (BMI, odds ratio for 1-standard-deviation increase (OR) 1.28, 95% CI 1.08-1.52), waist circumference (WC, OR 1.48, 95% CI 1.18-1.84), waist-hip ratio (OR 1.53, 95% CI 1.16-2.02), systolic blood pressure (OR 1.19, 95% CI 1.00-1.43) and triglycerides (TG, OR 1.18, 95% CI 1.00-1.40). Subjects with elevated WC (> 80th percentile) and TG (> 50th percentile) had a twofold higher DD risk (age-sex-adjusted odds ratio 2.00, 95% CI 1.20-3.31, P = 0.008), whereas no such interplay was observed for BMI. In the Malmö cohort, BMI was similarly associated with DD; participants with both elevated BMI and TG were at higher DD risk (age-sex-adjusted odds ratio 1.61, 95% CI 1.18-2.20, P = 0.002).. Subjects with elevated WC and TG may have a higher long-term DD risk. Prevention targeting visceral obesity may help reduce the incidence of DD. Topics: Adult; Body Mass Index; Cetrimonium Compounds; Cohort Studies; Diastole; Drug Combinations; Female; Follow-Up Studies; France; Healthy Volunteers; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myristates; Nicotinic Acids; Obesity; Prospective Studies; Risk Factors; Simethicone; Stearic Acids; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left	2018

Article

Year

Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.

Clinical research in cardiology : official journal of the German Cardiac Society, 2018, Volume: 107, Issue:10

Diastolic dysfunction (DD) is increasingly common. However, its metabolic determinants are poorly known. This study aims to determine which metabolic and inflammatory features predict DD in initially healthy adults.. We prospectively analyzed the association between metabolic features and DD in 728 initially healthy adults aged 30-60 from Eastern France enrolled in the STANISLAS population-based cohort. Clinical and biological cardiovascular features were collected at baseline (1994-1995). DD was assessed twenty years later (2011-2016) by echocardiography using current international guidelines. For replication purposes, 1463 subjects from the Malmö Preventive Project cohort were analyzed.. In the STANISLAS cohort, 191 subjects (26.2%) developed DD. In age-sex-adjusted logistic models, significant predictors of DD were body mass index (BMI, odds ratio for 1-standard-deviation increase (OR) 1.28, 95% CI 1.08-1.52), waist circumference (WC, OR 1.48, 95% CI 1.18-1.84), waist-hip ratio (OR 1.53, 95% CI 1.16-2.02), systolic blood pressure (OR 1.19, 95% CI 1.00-1.43) and triglycerides (TG, OR 1.18, 95% CI 1.00-1.40). Subjects with elevated WC (> 80th percentile) and TG (> 50th percentile) had a twofold higher DD risk (age-sex-adjusted odds ratio 2.00, 95% CI 1.20-3.31, P = 0.008), whereas no such interplay was observed for BMI. In the Malmö cohort, BMI was similarly associated with DD; participants with both elevated BMI and TG were at higher DD risk (age-sex-adjusted odds ratio 1.61, 95% CI 1.18-2.20, P = 0.002).. Subjects with elevated WC and TG may have a higher long-term DD risk. Prevention targeting visceral obesity may help reduce the incidence of DD.

Topics: Adult; Body Mass Index; Cetrimonium Compounds; Cohort Studies; Diastole; Drug Combinations; Female; Follow-Up Studies; France; Healthy Volunteers; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myristates; Nicotinic Acids; Obesity; Prospective Studies; Risk Factors; Simethicone; Stearic Acids; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left

2018